VivoSense Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 5

VivoSense General Information

Description

Developer of real-world digital clinical measures designed to improve patient clinical research and care. The company's platform specializes in wearable sensor physiological monitoring alternatives for the delivery of digital biomarkers from wearable sensor data in regulated clinical trials, enabling researchers to obtain real-world data and analyze it appropriately and accurately in decisions, and evaluate risks associated with various medical treatments.

Contact Information

Formerly Known As
Vivonoetics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 23 Corporate Plaza Drive
  • Newport Coast, CA 92660
  • United States
+1 (858)
Primary Industry
Decision/Risk Analysis
Corporate Office
  • 23 Corporate Plaza Drive
  • Newport Coast, CA 92660
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VivoSense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 18-Oct-2024 Completed Generating Revenue
4. Later Stage VC (Series A1) 04-Mar-2022 Completed Generating Revenue
3. Grant 01-Jan-2020 Completed Generating Revenue
2. Later Stage VC (Series A) 29-May-2019 $2M $4M Completed Generating Revenue
1. Seed Round 01-Sep-2011 $2M $2M Completed Startup
To view VivoSense’s complete valuation and funding history, request access »

VivoSense Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A
Seed 1,306,666 $0.000100 $1.53 $1.53 1x $1.53 4.93%
To view VivoSense’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

VivoSense Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of real-world digital clinical measures designed to improve patient clinical research and care. The company's
Decision/Risk Analysis
Newport Coast, CA
35 As of 2026

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VivoSense Competitors (1)

One of VivoSense’s competitors is Koneksa, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Koneksa Venture Capital-Backed New York, NY
You’re viewing 1 of 1 competitors. Get the full list »

VivoSense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VivoSense Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Debiopharm Innovation Fund Corporate Venture Capital Minority
Draper Associates Venture Capital Minority
Perceptive Advisors Venture Capital Minority
Xontogeny Accelerator/Incubator Minority
U.S. Department of Health and Human Services Government
To view VivoSense’s complete investors history, request access »

VivoSense FAQs

  • When was VivoSense founded?

    VivoSense was founded in 2010.

  • Where is VivoSense headquartered?

    VivoSense is headquartered in Newport Coast, CA.

  • What is the size of VivoSense?

    VivoSense has 35 total employees.

  • What industry is VivoSense in?

    VivoSense’s primary industry is Decision/Risk Analysis.

  • Is VivoSense a private or public company?

    VivoSense is a Private company.

  • What is VivoSense’s current revenue?

    The current revenue for VivoSense is .

  • How much funding has VivoSense raised over time?

    VivoSense has raised $29M.

  • Who are VivoSense’s investors?

    Debiopharm Innovation Fund, Draper Associates, Perceptive Advisors, Xontogeny, and U.S. Department of Health and Human Services have invested in VivoSense.

  • Who are VivoSense’s competitors?

    Koneksa is a competitor of VivoSense.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process